Quantifying the use of connected digital products in clinical research
Quantifying the use of connected digital products in clinical research
复制标题
DOI：
10.1038/s41746-020-0259-x
复制
发表时间：
2020-04-03
影响因子：
15.2
通讯作者：
Stern, Ariel D.
中科院分区：
文献类型：
--
作者：
Marra, Caroline;Chen, Jacqueline L.;Stern, Ariel D.
近年来，互联技术的采用急剧增长，具有改善医疗保健服务、研究和患者体验的潜力。然而，关于正式临床研究中联网数字产品（例如捕获生理和行为指标的产品）的流行和使用的记录很少。使用 18 年的数据，我们记录了临床试验中互联数字产品的使用大幅增长（复合年增长率约为 34%），并表明这些产品已在研究的所有阶段和不同的试验赞助商群体中使用。我们确定了如何将此类互联产品集成到临床试验设计中的四个不同用例，并为参与临床研究的各个利益相关者提出了建议。
Over recent years, the adoption of connected technologies has grown dramatically, with potential for improving health care delivery, research, and patient experience. Yet, little has been documented about the prevalence and use of connected digital products (e.g., products that capture physiological and behavioral metrics) in formal clinical research. Using 18 years of data from , we document substantial growth in the use of connected digital products in clinical trials (similar to 34% CAGR) and show that these products have been used across all phases of research and by a diverse group of trial sponsors. We identify four distinct use cases for how such connected products have been integrated within clinical trial design and suggest implications for various stakeholders engaging in clinical research.